Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
There's a new COVID-19 variant called FLiRT: Here's what you need to know about it
USA Today· 7 days agoA new set of COVID-19 variants, nicknamed FLiRT, has been detected in wastewater surveillance,...
Red Lobster is closing down over 50 locations, and everything must go
Business Insider· 1 hour agoRed Lobster is closing over 50 locations across the US, per restaurant liquidator TAGeX Brands....
2 COVID variants called ‘FLiRT’ are making the rounds: Here are the symptoms
The Patriot-News· 5 days agoA new set of COVID-19 variants are spreading in the U.S. after being detected in wastewater...
CoreCivic, Inc. (NYSE:CXW) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoCoreCivic, Inc. (NYSE:CXW) Q1 2024 Earnings Call Transcript May 9, 2024 CoreCivic, Inc. isn’t one of...
Why Newsom’s allies in health care are slamming his budget
Politico· 4 hours agoIt now heads back to the...to get ahead of Arizona’s civil-war era abortion ban that was upheld by that state’s highest court. Though Arizona’s legislature subsequently repealed ...
Reclaiming The Fire in Your Belly | Navigating the challenges of female leadership
WFLA· 5 days agoBLOOM (TAMPA) – In the wake of the COVID-19 pandemic, female leaders are facing unprecedented...
What’s driving the anti-vax movement? | The Excerpt
USA TODAY via Yahoo News· 2 days agoDana Taylor: Hello and welcome to The Excerpt. I'm Dana Taylor. Today is Sunday, May 12th, 2024. Whether someone has or hasn't been vaccinated for COVID ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 22 hours agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 6 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...